Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Quaglino, P; Osella-Abate, S; Novelli, M; Lisa, F; Comessatti, A; Bernengo, MG
   Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern
   EUROPEAN JOURNAL OF DERMATOLOGY
   
   P. Quaglino et al., "Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern", EUR J DERM, 11(6), 2001, pp. 560-563
2. Fierro, MT; Novelli, M; Savoia, P; Cambleri, I; Quaglino, P; Osella-Abate, S; Bernengo, MG
   CD45RA+immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients
   JOURNAL OF CUTANEOUS PATHOLOGY
   
   M.T. Fierro et al., "CD45RA+immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients", J CUT PATH, 28(7), 2001, pp. 356-362
3. Salomone, B; Ponti, R; Gasco, MR; Ugazio, E; Quaglino, P; Osella-Abate, S; Bernengo, MG
   In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction
   CLINICAL & EXPERIMENTAL METASTASIS
   
   B. Salomone et al., "In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction", CLIN EXP M, 18(8), 2001, pp. 663-673
4. Osella-Abate, S; Zaccagna, A; Savoia, P; Quaglino, P; Salomone, B; Bernengo, MG
   Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy
   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
   
   S. Osella-Abate et al., "Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy", J AM ACAD D, 44(1), 2001, pp. 40-47
5. Vonderheid, EC; Bigler, RD; Kotecha, A; Boselli, CM; Lessin, SR; Bernengo, MG; Polansky, M
   Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome)
   JOURNAL OF INVESTIGATIVE DERMATOLOGY
   
   E.C. Vonderheid et al., "Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome)", J INVES DER, 117(3), 2001, pp. 654-662
6. Bernengo, MG; Novelli, M; Quaglino, P; Lisa, F; De Matteis, A; Savoia, P; Cappello, N; Fierro, MT
   The relevance of the CD4+CD26-subset in the identification of circulating Sezary cells
   BRITISH JOURNAL OF DERMATOLOGY
   
   M.G. Bernengo et al., "The relevance of the CD4+CD26-subset in the identification of circulating Sezary cells", BR J DERM, 144(1), 2001, pp. 125-135
7. Abate, SO; Savoia, P; Cambieri, I; Salomone, B; Quaglino, P; Bernengo, MG
   Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma
   MELANOMA RESEARCH
   
   S.O. Abate et al., "Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma", MELANOMA RE, 10(6), 2000, pp. 545-555
8. Bernengo, MG; Quaglino, P; Cappello, N; Lisa, F; Osella-Abate, S; Fierro, MT
   Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients
   MELANOMA RESEARCH
   
   M.G. Bernengo et al., "Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients", MELANOMA RE, 10(1), 2000, pp. 55-65
9. Novelli, M; Savoia, P; Cambieri, I; Ponti, R; Comessatti, A; Lisa, F; Bernengo, MG
   Collagenase digestion and mechanical disaggregation as a method to extractand immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas
   CLINICAL AND EXPERIMENTAL DERMATOLOGY
   
   M. Novelli et al., "Collagenase digestion and mechanical disaggregation as a method to extractand immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas", CLIN EXP D, 25(5), 2000, pp. 423-431
10. Savoia, P; Fierro, MT; Zaccagna, A; Bernengo, MG
    Metastatic melanoma of the heart
    JOURNAL OF SURGICAL ONCOLOGY
    
    P. Savoia et al., "Metastatic melanoma of the heart", J SURG ONC, 75(3), 2000, pp. 203-207
11. Savoia, P; Zaccagna, A; Bernengo, MG
    Inflammatory disseminated morphea profunda
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    P. Savoia et al., "Inflammatory disseminated morphea profunda", EUR J DERM, 9(8), 1999, pp. 654-656
12. Quaglino, P; Zaccagna, A; Verrone, A; Dardano, F; Bernengo, MG
    Mycosis fungoides in patients under 20 years of age: Report of 7 cases, review of the literature and study of the clinical course
    DERMATOLOGY
    
    P. Quaglino et al., "Mycosis fungoides in patients under 20 years of age: Report of 7 cases, review of the literature and study of the clinical course", DERMATOLOGY, 199(1), 1999, pp. 8-14
13. TOMASINI C; PUIATTI P; BERNENGO MG
    MULTIPLE PYOGENIC GRANULOMA OF THE PENIS
    SEXUALLY TRANSMITTED INFECTIONS
    
    C. Tomasini et al., "MULTIPLE PYOGENIC GRANULOMA OF THE PENIS", SEXUALLY TRANSMITTED INFECTIONS, 74(3), 1998, pp. 221-222
14. Fierro, MT; Quaglino, P; Savoia, P; Verrone, A; Bernengo, MG
    Systemic polychemotherapy in the treatment of primary cutaneous lymphomas:a clinical follow-up study of 81 patients treated with COP or CHOP
    LEUKEMIA & LYMPHOMA
    
    M.T. Fierro et al., "Systemic polychemotherapy in the treatment of primary cutaneous lymphomas:a clinical follow-up study of 81 patients treated with COP or CHOP", LEUK LYMPH, 31(5-6), 1998, pp. 583-588
15. SAVOIA P; QUAGLINO P; VERRONE A; BERNENGO MG
    MULTIPLE PRIMARY MELANOMAS - ANALYSIS OF 49 CASES
    Melanoma research
    
    P. Savoia et al., "MULTIPLE PRIMARY MELANOMAS - ANALYSIS OF 49 CASES", Melanoma research, 8(4), 1998, pp. 361-366
16. BERNENGO MG; QUAGLINO P; NOVELLI M; CAPPELLO N; DOVEIL GC; LISA E; DEMATTEIS A; FIERRO MT; APPINO A
    PROGNOSTIC FACTORS IN SEZARY-SYNDROME - A MULTIVARIATE-ANALYSIS OF CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL FEATURES
    Annals of oncology
    
    M.G. Bernengo et al., "PROGNOSTIC FACTORS IN SEZARY-SYNDROME - A MULTIVARIATE-ANALYSIS OF CLINICAL, HEMATOLOGICAL AND IMMUNOLOGICAL FEATURES", Annals of oncology, 9(8), 1998, pp. 857-863
17. SAVOIA P; NOVELLI M; DEMATTEIS A; VERRONE A; BERNENGO MG
    EFFECTS OF TOPICAL CALCIPOTRIOL ON THE EXPRESSION OF ADHESION MOLECULES IN PSORIASIS
    Journal of cutaneous pathology
    
    P. Savoia et al., "EFFECTS OF TOPICAL CALCIPOTRIOL ON THE EXPRESSION OF ADHESION MOLECULES IN PSORIASIS", Journal of cutaneous pathology, 25(2), 1998, pp. 89-94
18. QUAGLINO P; TOMASINI C; NOVELLI M; COLONNA S; BERNENGO MG
    IMMUNOHISTOLOGIC FINDINGS AND ADHESION MOLECULE PATTERN IN PRIMARY PURE CUTANEOUS ROSAI-DORFMAN-DISEASE WITH XANTHOMATOUS FEATURES
    The American journal of dermatopathology
    
    P. Quaglino et al., "IMMUNOHISTOLOGIC FINDINGS AND ADHESION MOLECULE PATTERN IN PRIMARY PURE CUTANEOUS ROSAI-DORFMAN-DISEASE WITH XANTHOMATOUS FEATURES", The American journal of dermatopathology, 20(4), 1998, pp. 393-398
19. FIERRO M; DOVEIL GC; QUAGLINO P; SAVOIA P; VERRONE A; BERNENGO MG
    COMBINATION OF ETOPOSIDE, IDARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE AND BLEOMYCIN (VICOP-B) IN THE TREATMENT OF ADVANCED CUTANEOUS T-CELL LYMPHOMA
    Dermatology
    
    M. Fierro et al., "COMBINATION OF ETOPOSIDE, IDARUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE AND BLEOMYCIN (VICOP-B) IN THE TREATMENT OF ADVANCED CUTANEOUS T-CELL LYMPHOMA", Dermatology, 194(3), 1997, pp. 268-272
20. PUGLIESE A; SAVARINO A; CANTAMESSA C; BERNENGO MG
    DETECTION OF HIV P24 FROM ANTIGEN-PRESENTING MONOCYTES FOR EARLY DIAGNOSIS OF HIV-1 INFECTION
    Panminerva Medica
    
    A. Pugliese et al., "DETECTION OF HIV P24 FROM ANTIGEN-PRESENTING MONOCYTES FOR EARLY DIAGNOSIS OF HIV-1 INFECTION", Panminerva Medica, 39(3), 1997, pp. 159-164
21. QUAGLIANO P; LISA F; CAPPELLO N; ZACCAGNA A; BERNENGO MG
    MACROPHAGE-MEDIATED ANTITUMOR IMMUNOSTIMULATOR OR IMMUNO-SUPPRESSION MODULATES IL-2 THERAPEUTIC EFFICACY IN ADVANCED METASTATIC MELANOMA (MM) PATIENTS
    Journal of investigative dermatology
    
    P. Quagliano et al., "MACROPHAGE-MEDIATED ANTITUMOR IMMUNOSTIMULATOR OR IMMUNO-SUPPRESSION MODULATES IL-2 THERAPEUTIC EFFICACY IN ADVANCED METASTATIC MELANOMA (MM) PATIENTS", Journal of investigative dermatology, 109(3), 1997, pp. 448-448
22. BERNENGO MG; FIERRO MT; QUAGLINO P; VERRONE A
    FLUDARABINE PHOSPHATE IN ADVANCED MYCOSIS-FUNGOIDES SEZARY-SYNDROME -A PHASE-II TRIAL
    Journal of investigative dermatology
    
    M.G. Bernengo et al., "FLUDARABINE PHOSPHATE IN ADVANCED MYCOSIS-FUNGOIDES SEZARY-SYNDROME -A PHASE-II TRIAL", Journal of investigative dermatology, 109(3), 1997, pp. 490-490
23. BERNENGO MG; QUAGLINO P; NOVELLI M; CAPPELLO N; DOVEIL GC; LISA F; DEMATTEIS A; FIERRO MT; APPINO A
    PROGNOSTIC FACTORS IN SEZARY-SYNDROME
    Journal of investigative dermatology
    
    M.G. Bernengo et al., "PROGNOSTIC FACTORS IN SEZARY-SYNDROME", Journal of investigative dermatology, 109(3), 1997, pp. 491-491
24. BERNENGO MG; FIERRO MT; OUAGLINO P; SAVOIA P; APPINO A
    EFFECTIVENESS OF COP CHOP REGIMENS IN THE TREATMENT OF PRIMARY CUTANEOUS LYMPHOMAS - A CLINICAL FOLLOW-UP-STUDY OF 80 PATIENTS/
    Journal of investigative dermatology
    
    M.G. Bernengo et al., "EFFECTIVENESS OF COP CHOP REGIMENS IN THE TREATMENT OF PRIMARY CUTANEOUS LYMPHOMAS - A CLINICAL FOLLOW-UP-STUDY OF 80 PATIENTS/", Journal of investigative dermatology, 109(3), 1997, pp. 496-496
25. SAVOIA P; FIERRO MT; NOVELLI M; QUAGLINO P; VERRONE A; GEUNA M; BERNENGO MG
    CD56-POSITIVE CUTANEOUS LYMPHOMA - A POORLY RECOGNIZED ENTITY IN THE SPECTRUM OF PRIMARY CUTANEOUS DISEASE
    British journal of dermatology
    
    P. Savoia et al., "CD56-POSITIVE CUTANEOUS LYMPHOMA - A POORLY RECOGNIZED ENTITY IN THE SPECTRUM OF PRIMARY CUTANEOUS DISEASE", British journal of dermatology, 137(6), 1997, pp. 966-971
26. SAVOIA P; BERTERO M; NOVELLI M; FIERRO MT; BERNENGO MG
    BULLOUS, CUTANEOUS, PLEOMORPHIC, T-CELL LYMPHOMA - ANALYSIS OF INTEGRINS AND EXTRACELLULAR-MATRIX COMPONENTS
    EJD. European journal of dermatology
    
    P. Savoia et al., "BULLOUS, CUTANEOUS, PLEOMORPHIC, T-CELL LYMPHOMA - ANALYSIS OF INTEGRINS AND EXTRACELLULAR-MATRIX COMPONENTS", EJD. European journal of dermatology, 6(7), 1996, pp. 495-497
27. BERNENGO MG; DOVEIL GC; BERTERO M; QUAGLINO P; FIERRO MT; SAVOIA P; APPINO A; COLONNA S
    LOW-DOSE INTEGRATED CHEMOIMMUNOHORMONOTHERAPY WITH CISPLATIN, SUBCUTANEOUS INTERLEUKIN-2, ALPHA-INTERFERON AND TAMOXIFEN FOR ADVANCED METASTATIC MELANOMA - A PILOT-STUDY
    Melanoma research
    
    M.G. Bernengo et al., "LOW-DOSE INTEGRATED CHEMOIMMUNOHORMONOTHERAPY WITH CISPLATIN, SUBCUTANEOUS INTERLEUKIN-2, ALPHA-INTERFERON AND TAMOXIFEN FOR ADVANCED METASTATIC MELANOMA - A PILOT-STUDY", Melanoma research, 6(3), 1996, pp. 257-265
28. OUAGLINO P; LISA F; CAPPELLO N; NOVELLI M; BERNENGO MG
    CD7 EXPRESSION ON SEZARY CELLS IDENTIFIES A SUBGROUP OF SEZARY-SYNDROME PATIENTS WITH BETTER PROGNOSIS
    Journal of investigative dermatology
    
    P. Ouaglino et al., "CD7 EXPRESSION ON SEZARY CELLS IDENTIFIES A SUBGROUP OF SEZARY-SYNDROME PATIENTS WITH BETTER PROGNOSIS", Journal of investigative dermatology, 107(3), 1996, pp. 316-316
29. NOVELLI M; FIERRO MT; LISA F; DEMATTEIS A; OUAGLINO P; SAVOIA P; VERRONE A; CAMBIERI I; BERNENGO MG
    SKIN-INFILTRATING LYMPHOCYTE FLOW-CYTOMETRIC IMMUNOPHENOTYPING - AUTOMATED MECHANICAL BIOPSY AND CD45 GATING
    Journal of investigative dermatology
    
    M. Novelli et al., "SKIN-INFILTRATING LYMPHOCYTE FLOW-CYTOMETRIC IMMUNOPHENOTYPING - AUTOMATED MECHANICAL BIOPSY AND CD45 GATING", Journal of investigative dermatology, 107(3), 1996, pp. 324-324
30. FIERRO MT; SAVOIA P; NOVELLI M; GHISETTI V; LISA F; BERNENGO MG
    CLINICAL PRESENTATION AND IMMUNOLOGICAL FEATURES OF AN ITALIAN ATL CASE
    EJD. European journal of dermatology
    
    M.T. Fierro et al., "CLINICAL PRESENTATION AND IMMUNOLOGICAL FEATURES OF AN ITALIAN ATL CASE", EJD. European journal of dermatology, 5(8), 1995, pp. 695-700
31. DOVEIL GC; FIERRO MT; NOVELLI M; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
    ADJUVANT THERAPY OF STAGE IIIB MELANOMA WITH INTERFERON ALFA-2B - CLINICAL AND IMMUNOLOGICAL RELEVANCE
    Dermatology
    
    G.C. Doveil et al., "ADJUVANT THERAPY OF STAGE IIIB MELANOMA WITH INTERFERON ALFA-2B - CLINICAL AND IMMUNOLOGICAL RELEVANCE", Dermatology, 191(3), 1995, pp. 234-239
32. OUAGLINO P; FIERRO MT; SAVOIA P; NOVELLI M; LISA F; BERNENGO MG
    KM-93 EXPRESSION ON PERIPHERAL-BLOOD LYMPHOCYTES (PBL) IN INFLAMMATORY SKIN DISEASES, MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME
    Journal of investigative dermatology
    
    P. Ouaglino et al., "KM-93 EXPRESSION ON PERIPHERAL-BLOOD LYMPHOCYTES (PBL) IN INFLAMMATORY SKIN DISEASES, MYCOSIS-FUNGOIDES AND SEZARY-SYNDROME", Journal of investigative dermatology, 105(3), 1995, pp. 515-515
33. NOVELLI M; OUAGLINO P; FIERRO MT; SAVOIA P; DEMATTEIS A; BERNENGO MG
    CD4- EVALUATION IS A MORE USEFUL DIAGNOSTIC PARAMETER THAN CD4+CD7- IN SEZARY-SYNDROME (SS)(CD26)
    Journal of investigative dermatology
    
    M. Novelli et al., "CD4- EVALUATION IS A MORE USEFUL DIAGNOSTIC PARAMETER THAN CD4+CD7- IN SEZARY-SYNDROME (SS)(CD26)", Journal of investigative dermatology, 105(3), 1995, pp. 515-515
34. SAVOIA P; FIERRO MT; NOVELLI M; VERRONE A; OUAGLINO P; BERNENGO MG
    CD26 EXPRESSION ON KERATINOCYTES IN NORMAL SKIN, INFLAMMATORY SKIN DISEASES AND CUTANEOUS T-CELL LYMPHOMAS (CTCL)
    Journal of investigative dermatology
    
    P. Savoia et al., "CD26 EXPRESSION ON KERATINOCYTES IN NORMAL SKIN, INFLAMMATORY SKIN DISEASES AND CUTANEOUS T-CELL LYMPHOMAS (CTCL)", Journal of investigative dermatology, 105(3), 1995, pp. 515-515
35. CASCINELLI N; FOA R; PARMIANI G; ARIENTI F; BELLI F; BERNENGO MG; CLEMENTE C; COLOMBO MP; GUARINI A; ILLENI MT; MASCHERONI L; MELANI C; PRADA A; SULESUSO J
    ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-4 TRANSDUCED, ALLOGENEIC MELANOMA-CELLS - A PHASE I-II STUDY
    Human gene therapy
    
    N. Cascinelli et al., "ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-4 TRANSDUCED, ALLOGENEIC MELANOMA-CELLS - A PHASE I-II STUDY", Human gene therapy, 5(8), 1994, pp. 1059-1064
36. SAVOIA P; NOVELLI M; BERTERO M; BERNENGO MG
    ADHESION MOLECULES IN LYMPHOMATOID GRANULOMATOSIS
    Dermatology
    
    P. Savoia et al., "ADHESION MOLECULES IN LYMPHOMATOID GRANULOMATOSIS", Dermatology, 189(1), 1994, pp. 9-15
37. BAJETTA E; DILEO A; ZAMPINO MG; SERTOLI MR; COMELLA G; BARDUAGNI M; GIANNOTTI B; QUEIROLO P; TRIBBIA G; BERNENGO MG; MENICHETTI ET; PALMERI S; RUSSO A; CRISTOFOLINI M; ERBAZZI A; FOWST C; CRISCUOLO D; BUFALINO R; ZILEMBO N; CASCINELLI N
    MULTICENTER RANDOMIZED TRIAL OF DACARBAZINE ALONE OR IN COMBINATION WITH 2 DIFFERENT DOSES AND SCHEDULES OF INTERFERON ALFA-2A IN THE TREATMENT OF ADVANCED MELANOMA
    Journal of clinical oncology
    
    E. Bajetta et al., "MULTICENTER RANDOMIZED TRIAL OF DACARBAZINE ALONE OR IN COMBINATION WITH 2 DIFFERENT DOSES AND SCHEDULES OF INTERFERON ALFA-2A IN THE TREATMENT OF ADVANCED MELANOMA", Journal of clinical oncology, 12(4), 1994, pp. 806-811
38. BERTERO M; NOVELLI M; FIERRO MT; BERNENGO MG
    MANTLE ZONE LYMPHOMA - AN IMMUNOHISTOLOGIC STUDY OF SKIN-LESIONS
    Journal of the American Academy of Dermatology
    
    M. Bertero et al., "MANTLE ZONE LYMPHOMA - AN IMMUNOHISTOLOGIC STUDY OF SKIN-LESIONS", Journal of the American Academy of Dermatology, 30(1), 1994, pp. 23-30
39. NOVELLI M; FIERRO MT; QUAGLINO P; LISA F; DOVEIL GC; BERNENGO MG
    CD26(DPP-IV) - A USEFUL MARKER IN SEZARY-SYNDROME
    Journal of investigative dermatology
    
    M. Novelli et al., "CD26(DPP-IV) - A USEFUL MARKER IN SEZARY-SYNDROME", Journal of investigative dermatology, 103(3), 1994, pp. 448-448
40. FIERRO MT; BERTERO M; NOVELLI M; APPINO A; DOVEIL GC; COLONNA S; BERNENGO MG
    THERAPY FOR METASTATIC MELANOMA - EFFECTIVE COMBINATION OF DACARBAZINE, CARMUSTINE, CISPLATIN AND TAMOXIFEN
    Melanoma research
    
    M.T. Fierro et al., "THERAPY FOR METASTATIC MELANOMA - EFFECTIVE COMBINATION OF DACARBAZINE, CARMUSTINE, CISPLATIN AND TAMOXIFEN", Melanoma research, 3(2), 1993, pp. 127-131